Michelle Outeda-García

Statistics

Publications

Citations

191

H-Index

Active since

2023

Affiliations

Instituto de Investigación Biomédica de A Coruña(Current)

Complexo Hospitalario Universitario A Coruña

Universidade de Santiago de Compostela

Centro de Investigación Biomédica en Red

Center for Research in Molecular Medicine and Chronic Diseases

Michelle Outeda-García is an author at Instituto de Investigación Biomédica de A Coruña specializing in antimicrobial resistance, antibiotic resistance, and life sciences.

ORCID

Publications per year

2023–2025

Publications

Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions

Tania Blanco-Martín, Isaac Alonso-García, Lucía González-Pinto et al. · International Journal of Antimicrobial Agents · 2024 · 31 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain

Juan Carlos Vázquez-Ucha, Isaac Alonso-García, Paula Guijarro-Sánchez et al. · International Journal of Antimicrobial Agents · 2023 · 30 citations · Full text

Pharmacy, Pharmacology, Antimicrobial Pharmacotherapy +12

Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against <i>Pseudomonas aeruginosa</i>

Lucía González-Pinto, Isaac Alonso-García, Tania Blanco-Martín et al. · Journal of Antimicrobial Chemotherapy · 2024 · 28 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1

Cristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Juan Carlos Vázquez-Ucha et al. · Antimicrobial Agents and Chemotherapy · 2023 · 21 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales

Tania Blanco-Martín, Inmaculada López-Hernández, Belén Aracil et al. · Antimicrobial Agents and Chemotherapy · 2024 · 21 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

1–5 of 9